Literature DB >> 7150470

Natural history of smouldering leukaemia.

A S Joseph, K I Cinkotai, L Hunt, C G Geary.   

Abstract

The natural history of 45 cases of smouldering leukaemia has been studied. Males and females were equally represented, with a median age of 60.5. The median survival of the whole group was only 20 months, but rare cases lived 10 years or longer. 38% developed acute leukaemia; the remainder usually died of the results of marrow failure. Although it was possible to divide these marrow dysplasias morphologically into 3 major subgroups (refractory anaemia with excess of myeloblasts, chronic myelomonocytic leukaemia and chronic erythraemic myelosis), several displayed transitional features. Many showed refractory macrocytosis at diagnosis. The survival of the 3 groups was similar, though patients with high monocyte counts tended to present with less anaemia and fared rather better than the others. Statistical analysis suggests that increasing age, severe anaemia, thrombocytopenia and hepatomegaly are associated with a poor prognosis. Chemotherapy, when attempted, was usually unsuccessful.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150470      PMCID: PMC2011081          DOI: 10.1038/bjc.1982.179

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Chronic myelomonocytic leukaemia.

Authors:  C G Geary; D Catovsky; E Wiltshaw; G R Milner; M C Scholes; S Van Noorden; L D Wadsworth; S Muldal; J E MacIver; D A Galton
Journal:  Br J Haematol       Date:  1975-07       Impact factor: 6.998

2.  Chronic erythromonocytic leukemia.

Authors:  G O Broun
Journal:  Am J Med       Date:  1969-11       Impact factor: 4.965

3.  [Refractory anemia with excess myeloblasts in the bone marrow. Study of 11 cases].

Authors:  B Dreyfus; H Rochant; C Sultan; J P Clauvel; J Yvart; A M Chesneau
Journal:  Presse Med       Date:  1970-02-14       Impact factor: 1.228

4.  Cell-cell interaction in erythropoiesis. Role of human monocytes.

Authors:  J J Rinehart; E D Zanjani; B Nomdedeu; B J Gormus; M E Kaplan
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

5.  Subacute myeloid leukemia: a clinical review.

Authors:  J R Cohen; W P Creger; P L Greenberg; S L Schrier
Journal:  Am J Med       Date:  1979-06       Impact factor: 4.965

6.  The distribution of erythroblast iron in sideroblastic anaemias.

Authors:  R Hall; M S Losowsky
Journal:  Br J Haematol       Date:  1966-05       Impact factor: 6.998

7.  Preleukemic states. I. Definition and classification. II. Refractory anemia with an excess of myeloblasts in the bone marrow (smoldering acute leukemia).

Authors:  B Dreyfus
Journal:  Nouv Rev Fr Hematol Blood Cells       Date:  1976

8.  Studies on human preleukaemia. IV. Clinical and prognostic significance of sideroblasts in aregenerative anaemia with hypercellular bone marrow.

Authors:  R Hast
Journal:  Scand J Haematol       Date:  1978-11

9.  In vivo plasma and urine folate binding after ingestation of 3H-folic acid and 14C-methyl-folate.

Authors:  F P Retief; A Du P Heyns; M Oosthuizen; O R Van Reenen
Journal:  Br J Haematol       Date:  1976-07       Impact factor: 6.998

10.  Bone marrow culture studies in refractory cytopenia and 'smouldering leukaemia'.

Authors:  G R Milner; N G Testa; C G Geary; T M Dexter; S Muldal; J E MacIver; L G Lajtha
Journal:  Br J Haematol       Date:  1977-02       Impact factor: 6.998

View more
  5 in total

1.  Evaluation of macrocytosis in routine hemograms.

Authors:  P Veda
Journal:  Indian J Hematol Blood Transfus       Date:  2012-02-08       Impact factor: 0.900

Review 2.  Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.

Authors:  D M Layton; G J Mufti
Journal:  Blut       Date:  1986-12

3.  Effects of retinoids on in vitro differentiation of bone marrow cells in the myelodysplastic syndrome.

Authors:  R Hast; M Beksac; S Axdorph; A M Sjögren; A Ost; P Reizenstein
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

Review 4.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

5.  Haematological improvement with conservative management in an infant with myelodysplasia.

Authors:  A J Emmerson; R J Grace; H Grech; C M Stern; T C Pearson
Journal:  J R Soc Med       Date:  1992-08       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.